Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004029249 | SCV003876730 | uncertain significance | not specified | 2023-01-31 | criteria provided, single submitter | clinical testing | The c.1082A>G (p.N361S) alteration is located in exon 10 (coding exon 10) of the SUCLG2 gene. This alteration results from a A to G substitution at nucleotide position 1082, causing the asparagine (N) at amino acid position 361 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome |
RCV000845065 | SCV000986906 | not provided | Mitochondrial DNA depletion syndrome 9 | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance on 10-30-2014 by Lab or GTR ID 320284. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |